Clinical Trials

Spur Therapeutics Pioneers Gene Therapy with New Focus on Chronic Diseases
Research & Development Spur Therapeutics Pioneers Gene Therapy with New Focus on Chronic Diseases

Spur Therapeutics, previously known as Freeline Therapeutics, is making waves in the field of genetic medicine with its rebranding and renewed mission to revolutionize the treatment of chronic diseases through gene therapy. The company's ambitious initiatives encompass innovative research,

Spur Therapeutics Expands Gene Therapy Horizons with Strategic Rebranding
Research & Development Spur Therapeutics Expands Gene Therapy Horizons with Strategic Rebranding

Freeline Therapeutics, known for its pioneering work in gene therapy, has unveiled a new identity and an expanded mission, rebranding itself as Spur Therapeutics. This transformation marks a significant step towards a broader and more ambitious vision that includes tackling both rare genetic

Mustang Bio's CAR T Therapy Shows Promise for Rare Blood Cancer Treatment
Research & Development Mustang Bio's CAR T Therapy Shows Promise for Rare Blood Cancer Treatment

Advancements in cancer treatments have always been a focal point in medical research. Mustang Bio, Inc. (Nasdaq: MBIO) has recently made significant strides in the battle against Waldenstrom macroglobulinemia (WM), a rare type of blood cancer. Their latest clinical trial results for MB-106, a

Is Immunology the Next Frontier for Biopharma Giants?
Research & Development Is Immunology the Next Frontier for Biopharma Giants?

The biopharma industry stands at the crossroads of innovation and necessity as it leans into the burgeoning field of immunology. With the global immunology market anticipated to grow exponentially in the coming years, reaching numbers second only to oncology, major players and emerging startups

How Did the FDA Shape Drug Approvals in 2023-2024?
Research & Development How Did the FDA Shape Drug Approvals in 2023-2024?

Throughout 2023 and 2024, the U.S. Food and Drug Administration (FDA) played a pivotal role in the pharmaceutical and biotechnology sectors, not only by approving a significant number of new drugs but also by pushing the boundaries of innovation. These two years were marked by a notable surge in

FDA Drug Approvals Show Progress in Gene Therapy and Safety
Research & Development FDA Drug Approvals Show Progress in Gene Therapy and Safety

The landscape of medical treatment and drug development is experiencing a new dawn as the U.S. Food and Drug Administration (FDA) plays a pivotal role in ushering in an era where the once unimaginable becomes reality. With a discerning eye on cutting-edge therapies, especially in gene therapy and

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later